Page results
-
This patient information will describe what having a transverse vaginal septum means, how it can affect you, and what are the treatment options.
-
This page explains who you will meet and what to expect at your appointment with the adolescent gynaecology team at UCLH.
-
This information will help you understand your forthcoming treatment and contains answers to many frequently asked questions.
-
Over half a million non-sterile blue gloves have been saved from landfill since we launched our Gloves Off initiative in May last year.
-
This is a speech and language therapy service for deaf or hard of hearing adults who are having communication difficulties because of a hearing loss. The primary focus of the service is to help with spoken English skills.
-
The head and neck speech and language therapy team provide a highly specialist service to both inpatients and outpatients who may experience difficulty swallowing or speaking following treatment for head and neck cancer.
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
The oesophageal and stomach surgery service works very closely with the specialist Upper Gastrointestinal (GI) service, gastroenterology, nutrition, oncology and radiology departments at UCLH. It comprises UCLH-based and Barts Health-based surgeons.
-
Alternatives to Accident and Emergency (A&E) and attending the Emergency Department (Casualty) at UCLH
-
This page provides general information about the procedure called anterior cervical discectomy.
File results
-
FOI/2024/0513 - Robotic platforms for surgery costs/ contract
-
FOI/2024/0514 - Viscosupplementation injections/ spend
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0395 - Treatment and services for duchenne muscular dystrophy